Global Over-The-Counter (OTC) Drugs Market Research Report 2021

Publisher Name :
Date: 22-Jan-2021
No. of pages: 117
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Cold and Flu Products

- Analgesics

- Dermatological Products

- Gastrointestinal Products

- Vitamin

- Other

Segment by Application

- Hospital Pharmacy

- Retail Pharmacy

- Online Pharmacy

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Bayer

- Boehringer Ingelheim

- GSK

- Novartis

- Pfizer

- PGT healthcare

- Sanofi

- Teva Pharmaceuticals

- Takeda

- Cipla

- Sun Pharmaceutical Industries

- Glenmark

- Innovus Pharmaceuticals

Global Over-The-Counter (OTC) Drugs Market Research Report 2021

Table of Contents
1 Over-The-Counter (OTC) Drugs Market Overview
1.1 Product Overview and Scope of Over-The-Counter (OTC) Drugs
1.2 Over-The-Counter (OTC) Drugs Segment by Type
1.2.1 Global Over-The-Counter (OTC) Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Cold and Flu Products
1.2.3 Analgesics
1.2.4 Dermatological Products
1.2.5 Gastrointestinal Products
1.2.6 Vitamin
1.2.7 Other
1.3 Over-The-Counter (OTC) Drugs Segment by Application
1.3.1 Over-The-Counter (OTC) Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Over-The-Counter (OTC) Drugs Market Size Estimates and Forecasts
1.4.1 Global Over-The-Counter (OTC) Drugs Revenue 2016-2027
1.4.2 Global Over-The-Counter (OTC) Drugs Sales 2016-2027
1.4.3 Over-The-Counter (OTC) Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Over-The-Counter (OTC) Drugs Market Competition by Manufacturers
2.1 Global Over-The-Counter (OTC) Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Over-The-Counter (OTC) Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Over-The-Counter (OTC) Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Over-The-Counter (OTC) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Over-The-Counter (OTC) Drugs Market Competitive Situation and Trends
2.5.1 Over-The-Counter (OTC) Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Over-The-Counter (OTC) Drugs Players Market Share by Revenue
2.5.3 Global Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Over-The-Counter (OTC) Drugs Retrospective Market Scenario by Region
3.1 Global Over-The-Counter (OTC) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Over-The-Counter (OTC) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
3.3.1 North America Over-The-Counter (OTC) Drugs Sales by Country
3.3.2 North America Over-The-Counter (OTC) Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
3.4.1 Europe Over-The-Counter (OTC) Drugs Sales by Country
3.4.2 Europe Over-The-Counter (OTC) Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Over-The-Counter (OTC) Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Over-The-Counter (OTC) Drugs Sales by Region
3.5.2 Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
3.6.1 Latin America Over-The-Counter (OTC) Drugs Sales by Country
3.6.2 Latin America Over-The-Counter (OTC) Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Over-The-Counter (OTC) Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country
3.7.2 Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Over-The-Counter (OTC) Drugs Historic Market Analysis by Type
4.1 Global Over-The-Counter (OTC) Drugs Sales Market Share by Type (2016-2021)
4.2 Global Over-The-Counter (OTC) Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Over-The-Counter (OTC) Drugs Price by Type (2016-2021)
5 Global Over-The-Counter (OTC) Drugs Historic Market Analysis by Application
5.1 Global Over-The-Counter (OTC) Drugs Sales Market Share by Application (2016-2021)
5.2 Global Over-The-Counter (OTC) Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Over-The-Counter (OTC) Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Corporation Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bayer Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Boehringer Ingelheim Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 GSK Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 PGT healthcare
6.6.1 PGT healthcare Corporation Information
6.6.2 PGT healthcare Description and Business Overview
6.6.3 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 PGT healthcare Product Portfolio
6.6.5 PGT healthcare Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Teva Pharmaceuticals
6.8.1 Teva Pharmaceuticals Corporation Information
6.8.2 Teva Pharmaceuticals Description and Business Overview
6.8.3 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Teva Pharmaceuticals Product Portfolio
6.8.5 Teva Pharmaceuticals Recent Developments/Updates
6.9 Takeda
6.9.1 Takeda Corporation Information
6.9.2 Takeda Description and Business Overview
6.9.3 Takeda Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Takeda Product Portfolio
6.9.5 Takeda Recent Developments/Updates
6.10 Cipla
6.10.1 Cipla Corporation Information
6.10.2 Cipla Description and Business Overview
6.10.3 Cipla Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Cipla Product Portfolio
6.10.5 Cipla Recent Developments/Updates
6.11 Sun Pharmaceutical Industries
6.11.1 Sun Pharmaceutical Industries Corporation Information
6.11.2 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Description and Business Overview
6.11.3 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Sun Pharmaceutical Industries Product Portfolio
6.11.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.12 Glenmark
6.12.1 Glenmark Corporation Information
6.12.2 Glenmark Over-The-Counter (OTC) Drugs Description and Business Overview
6.12.3 Glenmark Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Glenmark Product Portfolio
6.12.5 Glenmark Recent Developments/Updates
6.13 Innovus Pharmaceuticals
6.13.1 Innovus Pharmaceuticals Corporation Information
6.13.2 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Description and Business Overview
6.13.3 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Innovus Pharmaceuticals Product Portfolio
6.13.5 Innovus Pharmaceuticals Recent Developments/Updates
7 Over-The-Counter (OTC) Drugs Manufacturing Cost Analysis
7.1 Over-The-Counter (OTC) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Over-The-Counter (OTC) Drugs
7.4 Over-The-Counter (OTC) Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Over-The-Counter (OTC) Drugs Distributors List
8.3 Over-The-Counter (OTC) Drugs Customers
9 Over-The-Counter (OTC) Drugs Market Dynamics
9.1 Over-The-Counter (OTC) Drugs Industry Trends
9.2 Over-The-Counter (OTC) Drugs Growth Drivers
9.3 Over-The-Counter (OTC) Drugs Market Challenges
9.4 Over-The-Counter (OTC) Drugs Market Restraints
10 Global Market Forecast
10.1 Over-The-Counter (OTC) Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Over-The-Counter (OTC) Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Over-The-Counter (OTC) Drugs by Type (2022-2027)
10.2 Over-The-Counter (OTC) Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Over-The-Counter (OTC) Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Over-The-Counter (OTC) Drugs by Application (2022-2027)
10.3 Over-The-Counter (OTC) Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Over-The-Counter (OTC) Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Over-The-Counter (OTC) Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Over-The-Counter (OTC) Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Over-The-Counter (OTC) Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Over-The-Counter (OTC) Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Over-The-Counter (OTC) Drugs Covered in This Study
Table 5. Global Over-The-Counter (OTC) Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Over-The-Counter (OTC) Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Over-The-Counter (OTC) Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Over-The-Counter (OTC) Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Over-The-Counter (OTC) Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Over-The-Counter (OTC) Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Over-The-Counter (OTC) Drugs Product Type
Table 12. Global Over-The-Counter (OTC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Over-The-Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over-The-Counter (OTC) Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Over-The-Counter (OTC) Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Over-The-Counter (OTC) Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Over-The-Counter (OTC) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Over-The-Counter (OTC) Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Over-The-Counter (OTC) Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Over-The-Counter (OTC) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Over-The-Counter (OTC) Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Over-The-Counter (OTC) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Over-The-Counter (OTC) Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Over-The-Counter (OTC) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Over-The-Counter (OTC) Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Over-The-Counter (OTC) Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Over-The-Counter (OTC) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Over-The-Counter (OTC) Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Over-The-Counter (OTC) Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Over-The-Counter (OTC) Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Over-The-Counter (OTC) Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Over-The-Counter (OTC) Drugs Revenue Share by Type (2016-2021)
Table 42. Global Over-The-Counter (OTC) Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Over-The-Counter (OTC) Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Over-The-Counter (OTC) Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Over-The-Counter (OTC) Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Over-The-Counter (OTC) Drugs Revenue Share by Application (2016-2021)
Table 47. Global Over-The-Counter (OTC) Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. Bayer Corporation Information
Table 49. Bayer Description and Business Overview
Table 50. Bayer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Bayer Over-The-Counter (OTC) Drugs Product
Table 52. Bayer Recent Developments/Updates
Table 53. Boehringer Ingelheim Corporation Information
Table 54. Boehringer Ingelheim Description and Business Overview
Table 55. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product
Table 57. Boehringer Ingelheim Recent Developments/Updates
Table 58. GSK Corporation Information
Table 59. GSK Description and Business Overview
Table 60. GSK Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. GSK Over-The-Counter (OTC) Drugs Product
Table 62. GSK Recent Developments/Updates
Table 63. Novartis Corporation Information
Table 64. Novartis Description and Business Overview
Table 65. Novartis Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Novartis Over-The-Counter (OTC) Drugs Product
Table 67. Novartis Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Pfizer Over-The-Counter (OTC) Drugs Product
Table 72. Pfizer Recent Developments/Updates
Table 73. PGT healthcare Corporation Information
Table 74. PGT healthcare Description and Business Overview
Table 75. PGT healthcare Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. PGT healthcare Over-The-Counter (OTC) Drugs Product
Table 77. PGT healthcare Recent Developments/Updates
Table 78. Sanofi Corporation Information
Table 79. Sanofi Description and Business Overview
Table 80. Sanofi Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Sanofi Over-The-Counter (OTC) Drugs Product
Table 82. Sanofi Recent Developments/Updates
Table 83. Teva Pharmaceuticals Corporation Information
Table 84. Teva Pharmaceuticals Description and Business Overview
Table 85. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product
Table 87. Teva Pharmaceuticals Recent Developments/Updates
Table 88. Takeda Corporation Information
Table 89. Takeda Description and Business Overview
Table 90. Takeda Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Takeda Over-The-Counter (OTC) Drugs Product
Table 92. Takeda Recent Developments/Updates
Table 93. Cipla Corporation Information
Table 94. Cipla Description and Business Overview
Table 95. Cipla Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Cipla Over-The-Counter (OTC) Drugs Product
Table 97. Cipla Recent Developments/Updates
Table 98. Sun Pharmaceutical Industries Corporation Information
Table 99. Sun Pharmaceutical Industries Description and Business Overview
Table 100. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product
Table 102. Sun Pharmaceutical Industries Recent Developments/Updates
Table 103. Glenmark Corporation Information
Table 104. Glenmark Description and Business Overview
Table 105. Glenmark Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Glenmark Over-The-Counter (OTC) Drugs Product
Table 107. Glenmark Recent Developments/Updates
Table 108. Innovus Pharmaceuticals Corporation Information
Table 109. Innovus Pharmaceuticals Description and Business Overview
Table 110. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product
Table 112. Innovus Pharmaceuticals Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Over-The-Counter (OTC) Drugs Distributors List
Table 116. Over-The-Counter (OTC) Drugs Customers List
Table 117. Over-The-Counter (OTC) Drugs Market Trends
Table 118. Over-The-Counter (OTC) Drugs Growth Drivers
Table 119. Over-The-Counter (OTC) Drugs Market Restraints
Table 120. Global Over-The-Counter (OTC) Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 121. Global Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Over-The-Counter (OTC) Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Over-The-Counter (OTC) Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Over-The-Counter (OTC) Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 125. Global Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Over-The-Counter (OTC) Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Over-The-Counter (OTC) Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Over-The-Counter (OTC) Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 129. Global Over-The-Counter (OTC) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Over-The-Counter (OTC) Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Over-The-Counter (OTC) Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Over-The-Counter (OTC) Drugs
Figure 2. Global Over-The-Counter (OTC) Drugs Market Share by Type in 2020 & 2027
Figure 3. Cold and Flu Products Product Picture
Figure 4. Analgesics Product Picture
Figure 5. Dermatological Products Product Picture
Figure 6. Gastrointestinal Products Product Picture
Figure 7. Vitamin Product Picture
Figure 8. Other Product Picture
Figure 9. Global Over-The-Counter (OTC) Drugs Market Share by Application in 2020 & 2027
Figure 10. Hospital Pharmacy
Figure 11. Retail Pharmacy
Figure 12. Online Pharmacy
Figure 13. Global Over-The-Counter (OTC) Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Over-The-Counter (OTC) Drugs Market Size 2016-2027 (US$ Million)
Figure 15. Global Over-The-Counter (OTC) Drugs Sales 2016-2027 (K Units)
Figure 16. Global Over-The-Counter (OTC) Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Over-The-Counter (OTC) Drugs Sales Share by Manufacturers in 2020
Figure 18. Global Over-The-Counter (OTC) Drugs Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Over-The-Counter (OTC) Drugs Players: Market Share by Revenue in 2020
Figure 20. Over-The-Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Over-The-Counter (OTC) Drugs Sales Market Share by Region (2016-2021)
Figure 22. Global Over-The-Counter (OTC) Drugs Sales Market Share by Region in 2020
Figure 23. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Region (2016-2021)
Figure 24. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Region in 2020
Figure 25. U.S. Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Over-The-Counter (OTC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Over-The-Counter (OTC) Drugs by Type (2016-2021)
Figure 50. Sales Market Share of Over-The-Counter (OTC) Drugs by Application (2016-2021)
Figure 51. Sales Market Share of Over-The-Counter (OTC) Drugs by Application in 2020
Figure 52. Revenue Share of Over-The-Counter (OTC) Drugs by Application (2016-2021)
Figure 53. Revenue Share of Over-The-Counter (OTC) Drugs by Application in 2020
Figure 54. Manufacturing Cost Structure of Over-The-Counter (OTC) Drugs
Figure 55. Manufacturing Process Analysis of Over-The-Counter (OTC) Drugs
Figure 56. Over-The-Counter (OTC) Drugs Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs